Phathom Pharmaceuticals, Inc. (PHAT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Core Insights - The company has undergone significant changes in leadership over the past couple of years, with new executives bringing fresh perspectives and initiatives [1] Group 1: Leadership Changes - The new CEO, Steven Basta, joined the company nearly a year ago and was attracted to the opportunity due to the potential of the company's product to significantly improve patient quality of life [1] Group 2: Company Mission - The primary focus of the company is to deliver effective therapies that enhance the quality of life for patients, which aligns with its mission in the healthcare sector [1]